More than 300 million people worldwide are affected by allergic asthma, a multifactorial disorder influenced by a multitude of genetic and environmental factors. [1] [2] [3] Among pediatric patients, it is one of the leading causes of morbidity, affecting around 10% of children in the Western world. 4, 5 Although pharmacotherapy can effectively control asthma symptoms, no curative or effective prevention strategies exist. A number of epidemiologic studies demonstrated the protective effect of environmental factors in early childhood (eg, farm living or attending day care centers) on a child's asthma risk. 3, [6] [7] [8] [9] Moreover, maternal factors during pregnancy and lactation, such as microbiota, allergen exposure, stress, air pollution, and various others, were shown to influence a subject's allergic susceptibility. [10] [11] [12] [13] [14] Mucosal exposure to allergens can induce antigen-specific tolerance, 15 and the development of tolerance against allergens can start during prenatal life. In a murine model, we and others previously demonstrated that antigenic exposure of the mother, even before pregnancy, crucially influences the progeny's allergy risk. [16] [17] [18] In our study, tolerization of female mice before mating induced a long-lasting and antigen-specific protection from the allergic phenotype in the offspring, which depended on transfer of antigen-specific immunoglobulins either in utero or through breast milk after birth. IgG/allergen complexes, which induce antigen-specific regulatory T (Treg) cells. 16, 19 Because it is known that antigen transfer into the amniotic fluid (AF) can shape the fetal immune response, 20 we were interested in further elucidating the very early steps of perinatal tolerance priming.
The aim of the present study was to analyze by which mechanisms the mother's allergen experience before conception influences the offspring's allergic susceptibility. Specifically, we wanted to analyze to what extent maternofetal allergy prevention to harmless antigens, such as allergens acquired in female subjects before pregnancy, is influenced by B cells.
To this end, we analyzed the influence of allergen application before conception in wild-type (WT) and B cell-deficient mice. We used B cell-deficient mMT mice on a C57Bl/6 background, which lack the immunoglobulin m chain gene and have no mature B cells. 21, 22 Murine mothers received antigen before mating, and the allergic phenotype, as well as intrauterine antigen and immunoglobulin targeting, was analyzed in their offspring. Furthermore, the tolerogenic potency of AF from antigenexposed dams and the antigen-binding and Treg cell-inducing capacity of fetal and adult dendritic cells (DCs) were assessed.
Although maternal antigen exposure protected WT pups from allergy, it aggravated allergic airway inflammation in B celldeficient mice. The lack of B cells was associated with reduced maternofetal Treg cell priming during lactation and a marked impairment of intrauterine allergen uptake by fetal DCs. Moreover, AF-induced Treg cell priming after ovalbumin (OVA) exposure of pregnant dams was significantly reduced in B cell-deficient mice. Intrauterine allergen transfer and uptake by fetal DCs, as well as antigen-specific in vitro Treg cell priming, were restored after application of OVA complexed to antigen-specific IgG.
Taken together, our results support a decisive role for B cells and IgG during in utero priming of immunologic tolerance and might contribute to the development of potent prevention strategies for allergy and asthma.
METHODS Mice
Cgn/J (mMT) and WT C57BL/6J mice were obtained from the Jackson Laboratory (Bar Harbor, Me). OVA-specific T-cell receptor transgenic mice (C57BL/6-Tg[TcraTcrb]425Cbn/J;OT-II CD45.1) were provided by Oliver Pabst, Hannover Medical School (Hannover, Germany). All experiments were approved by local authorities (LAVES#10/0300). Mice were age/sex-matched between groups and housed under specific pathogen-free conditions.
Maternal antigen administration and murine model of allergic airway inflammation
Murine mothers were anesthetized with isoflurane and received 500 mg of OVA (grade V; Sigma-Aldrich, Hilden, Germany; product no. A5505, lot no. 038K7012) intranasally on days 26 and 23 before mating. Pups were tested in the allergic airway inflammation model with OVA (grade V) or blactoglobulin (BLG; Sigma-Aldrich; product no. L2506, lot no. 096K7009). Mice were intraperitoneally sensitized with OVA (20 mg) adsorbed to aluminum hydroxide (Thermo Fisher, Waltham, Mass), followed by intranasal challenges (20 mg), as described in Fig 1. For testing of tolerance induction, as shown in Fig E1 in this article' s Online Repository at www.jacionline. org, tolerization and induction of allergic airway inflammation were conducted in 8-to 10-week-old B cell-deficient mice, and LPS-free OVA (polymixinbased LPS clearance of grade V; Sigma) was used.
B-cell transfer
For B-cell transfer, CD19
1 cells were isolated from naive C57Bl/6 WT mice by means of magnetic cell sorting (MACS Mouse B Cell Isolation Kit; Miltenyi Biotec, Bergisch Gladbach, Germany). WT B cells (2 3 10 7 ) were injected intravenously into the tail veins of female mMT mice 10 days before mating.
Measurement of lung function
Invasive lung function was assessed, as described previously. 23 In brief, mice were anesthetized, and airway hyperresponsiveness was assessed under increasing doses of methacholine. 24 
Analysis of bronchoalveolar lavage fluid and lung histology
Bronchoalveolar lavage fluid (BALF), cytospin preparations, and lung histologies were performed, as described previously. 25 Histologic samples were photographed with an AxioCam-ICc1 camera and further analyzed with AxioVision/V4.8.2 software (Zeiss, Jena, Germany) and in-house programs. 25 Determination of antigen-specific immunoglobulin levels OVA-specific IgG 1 /IgE levels were determined by using ELISA, as previously described. 25 
ELISpot assay
Total and OVA-specific IgM antibody-secreting cells were assessed after overnight culture on precoated MultiScreen HTS-IP plates (Millipore, Schwalbach, Germany), followed by incubation with anti-mouse IgGhorseradish peroxidase (SouthernBiotech, Birmingham, Ala) and AEC substrate (Vector Laboratories, Peterborough, United Kingdom). Spots were scanned with the Eli.Scan F3200 (A.EL.VIS GmbH, Hannover, Germany).
Cytokine measurements
Antigen-specific restimulation was performed, as previously described. 25 Cytokines were measured with specific ELISAs (R&D Systems, Minneapolis, Minn) or cytometric bead arrays (BioLegend, San Diego, Calif; Affymetrix, Santa Clara, Calif), according to the manufacturer's recommendations.
Collection of AF, immune complex administration, and in vivo antigen tracking AF was collected, as previously described. 26 On pregnancy day 19/20 (matched experimental groups in each experiment), AF was collected from naive mice or OVA-treated mice before conception (2 3 500 mg administered intranasally on days 26 and 23 before mating and 40 mg of OVA Antigen and IC uptake in vitro by murine and human DCs
Murine fetal and adult splenocytes were coincubated with fluorescencelabelled OVA (100 mg/mL) or fluorescence-labeled OVA/IgG immune complex (OVA-IC; 100 mg/mL fluoOVA plus 200 mg/mL OVA-specific IgG 1 clone L71 preincubated for 30 minutes at 378C) at 378C for 10 minutes. Cells were washed 3 times and analyzed by using flow cytometry. All human cord blood experiments were approved by the local ethics committee, and all donors provided informed consent. Mononuclear cells from peripheral or cord blood were isolated by means of density centrifugation from healthy donors and placental blood from healthy pregnancies. All cord blood-donating mothers were nonatopic, and 2 donors of adult peripheral blood were atopic and had allergic rhinitis and atopic dermatitis, respectively (donor-specific data are included in Fig E6 in 
Western blot of AF
AF was mixed with loading buffer (Bio-Rad Laboratories, Munich, Germany), boiled for 10 minutes at 958C, and subjected to SDS-PAGE (7.5% AnykD-gel, Bio-Rad Laboratories) with consecutive nitrocellulose membrane transfer. Within each experiment, the same amounts of AF from each group were loaded (50-150 mg, same amount of protein per lane on each gel). OVA was detected with rabbit anti-OVA (Ab1221; Abcam, Cambridge, United Kingdom), followed by horseradish peroxidase-conjugated goat antimouse IgG 1 (Jackson ImmunoResearch, Suffolk, United Kingdom). Signals were captured by using enhanced chemiluminescence (Thermo Scientific, Rockford, Ill) in a luminescence imager (DNR Bio-Imaging, Jerusalem, Israel, and Chemidic, Bio-Rad Laboratories).
Antigen-specific T-cell priming
OVA-specific spleen and lymph node CD4 T cells were purified from OT-II/ CD45.1 mice by using magnetic-activated cell sorting (mouse CD4 T cell isolation kit, Miltenyi Biotec). For in vitro experiments, T cells were coincubated with adult or fetal DCs isolated by using magnetic-activated cell sorting (CD11c 1 spleen and lymph node T-cell populations of 500 to 5000 cells were detectable in more than 75% of both WT and deficient pups, which were then used for further analyses. T-cell priming was analyzed by using CD4 (Becton Dickinson), Vb5.1/5.2-T-cell receptor (Clone MR9-4), CD45.1, CD25, and forkhead box P3 (Foxp3; eBioscience, San Diego, Calif) with a FACSCanto II (Becton-Dickinson) and FlowJo software (version 10; TreeStar, Ashland, Ore).
Statistics
Graphs were created with GraphPad Prism 5 software (GraphPad Software, La Jolla, Calif). Depending on data structure, which was assessed by using Kolmogorov-Smirnov normality testing, the Student t test, or Mann-Whitney test (2 experimental groups) or 1-way ANOVA/Tukey or Kruskal-Wallis/Dunn testing (3 groups) were applied. Paired t testing or Wilcoxon matched-pair testing was applied to analyze adult versus fetal/cord IC uptake or paired cytokine stimulations from more than 1 experiment. After weaning, offspring were tested in the OVA-based allergic airway inflammation model. In some experiments B cell-deficient mothers received WT B cells by means of tail vein injection 3 days before the first OVA dose. Ag, Antigen; AHR, airway hyperresponsiveness; KO, knockout; i.n., intranasal; i.p., intraperitoneal; Tx, transplantation.
J ALLERGY CLIN IMMUNOL VOLUME 141, NUMBER 2 FIG 2. Preconception mucosal antigen application to the dam reduces allergic airway inflammation in the offspring but aggravates airway inflammation in B-cell knockout (KO) mice, which is abolished after transfer of B cells to B cell-deficient mothers before antigen administration. A-C, Offspring of tolerized WT mothers display reduced lung inflammation and mucus production in hematoxylin and eosin (H&E)-and periodic acid-Schiff (PAS)-stained and paraffin-embedded lung slices (Fig 2, A) , reduced airway inflammation in investigator-independent analysis of H&E-stained lung sections (Fig 2, B) , and reduced total cell numbers and eosinophilia in BALF (Fig 2, C) compared with the offspring of naive WT dams. D-F, In B-cell knockout offspring, maternal OVA administration leads to aggravated lung inflammation and mucus production (Fig 2, D) and increased airway inflammation (Fig 2, E) in investigator-independent analysis of H&E-stained lung sections and increased total numbers and eosinophils in the BALF (Fig 2, F) . G-I, B-cell transfer to B cell-deficient dams before antigen administration leads to reduced lung inflammation and mucus production (Fig 2, G) , reduced airway inflammation in investigator-independent analysis of H&E-stained lung sections (Fig 2, H) , and reduced total and eosinophil numbers in the BALF (Fig 2, I ) compared with offspring of tolerized B-cell knockout mothers without B-cell transfer. Graphs display means 1 SEMs. Alum, Control group; B cell Tx, allergic offspring of OVA exposed and B cell-transplanted dams; eos, eosinophils; lym, lymphocytes; mac, macrophages; neu, neutrophils; M ova OVA, allergic offspring of OVA-exposed dams; OVA, allergic group. Fig 2, A and B] and 2 representative experiments of > _3). *P < .05, **P < .01, and ***P < .001.
RESULTS
Allergic airway inflammation is inhibited by mucosal antigen application before mating in offspring of WT mice, whereas the same protocol increases airway inflammation in B cell-deficient mice, which is partly restored by B-cell transfer
To study the effect of B cells in the context of maternal antigen exposure before conception on the offspring's allergy risk, female WT and B cell-deficient mice received 2 doses of the model allergen OVA mucosally in the week before mating, and the progeny of these 2 different mouse strains was tested in a murine model of allergic airway inflammation (Fig 1) . In B cell-deficient mMT mice, 21 a targeted disruption in the gene encoding for Igm leads to a lack of mature B cells and immunoglobulins. In spite of their B-cell deficiency with resulting lack of CD19 1 CD5 1 regulatory B cells (see Fig E1, A) and impaired T-cell priming, 27 FIG 3 . Preconception mucosal OVA administration reduces antigen-specific immunoglobulin and cytokine production in WT offspring, whereas it increases antigen-specific cytokine responses in offspring of B celldeficient mice. This aggravation is partially abolished on B-cell transfer. A-D, Offspring of tolerized WT mice display reduced serum levels of OVA-specific IgE (Fig 3, A) and OVA-specific IgG 1 (Fig 3, B) and diminished antigen-specific cytokine production from splenocytes (Fig 3, C) and bronchial lymph node cells (Fig 3, D) . E-H, Offspring of OVA-exposed B cell-deficient mothers show no immunoglobulin production (Fig 3, E and F) but increased antigen-specific cytokine production by splenocytes (Fig 3, G) and bronchial lymph node cells (Fig 3, H) . I-L, In offspring of B cell-transplanted and OVA-exposed mMT mice, absent immunoglobulins (Fig 3, I and J) and reduced antigen-specific cytokine production after in vitro splenocyte (Fig 3, K) and bronchial lymph node cell (Fig 3, L) restimulation with OVA are observed. Graphs display means 1 SEMs. Alum, Control group; B cell Tx, allergic offspring of OVA-exposed and B cell-transplanted dams; eos, eosinophils; lym, lymphocytes; mac, macrophages; M ova OVA, allergic offspring of OVA-exposed dams; neu, neutrophils; OVA, allergic group. Groups: B cell KO, n > _ 7 mice per experimental group from 2 (Fig 3, F and G) and n > _ 3 mice per experimental group from 1 representative experiment (Fig 3, E and H) ; B cell KO 1Tx, n > _ 7 mice per experimental group from 2 (Fig 3, K) and n > _ 3 mice per experimental group from 1 representative experiment (Fig 3, I-L) ; WT, n > _ 11 mice per experimental group from 2 (Fig 3, A-C) and n > _ 4 mice per experimental group from 1 representative experiment (Fig 3, D) . *P < .05, **P < .01, and ***P < .001.
B cell-deficient mice have an asthma-like phenotype and can be successfully tolerized by mucosal antigen application (see Fig E1) . 22, 28, 29 In the progeny of WT mice, mucosal antigen administration before conception protected the offspring from allergic airway inflammation, as shown by reduced leukocytic infiltrates in hematoxylin and eosin-stained lung sections (Fig 2, A and B) , as well as reduced total cell and eosinophil numbers in BALF (Fig 2, C) . In contrast, antigen application to B cell-deficient female mice before conception did not protect the progeny from having an allergic phenotype but aggravated their allergic airway inflammation. Leukocytic infiltrates in lung sections, as well as total cell and eosinophil numbers in BALF, were significantly increased compared with findings in the offspring of B cell-deficient mice that did not receive OVA mucosally before mating (Fig 2, D, 
org).
To examine whether the proallergenic effect of maternal tolerization in B cell-deficient mice was antigen specific, we administered OVA to female B cell-deficient mice before mating and after weaning, whereas their progeny were tested in a model of allergic airway inflammation based on the unrelated antigen BLG (see Fig E3, A, in this article's Online Repository at www.jacionline.org). When immunized with BLG, the maternal intervention induced no significant changes of allergic symptoms in the progeny (see Fig E3, B-D) , confirming the antigen specificity of maternal immune priming, which had previously been shown by us and others for maternofetal tolerance induction in WT mice. [16] [17] [18] The B-cell and immunoglobulin repertoire in B cell-deficient mice can be restored partially by adoptive transfer of WT B cells. 27 WT B cells were transferred to B cell-deficient female mice before mucosal OVA application and consecutive mating to examine whether B-cell transfer to the mother abolished the proallergenic effect of preconception antigen administration. The transferred cells engrafted in recipient mice, as shown by enlarged spleens, detection of B220 Indeed, B-cell transfer before mucosal antigen application and mating of B cell-deficient mice reduced allergic airway inflammation in the offspring compared with that in pups from mothers that were treated comparably but did not receive B cells. The offspring of B cell-transplanted dams displayed significantly reduced eosinophilic airway inflammation in hematoxylin and eosin-stained lung sections and lower total and eosinophil BALF cell counts (Fig 2, G-I ).
Mucosal antigen application to female mice before mating results in inhibition of IgE and T H 2 cytokine production in WT mice but aggravates T H 2 cytokines in B cell-deficient mice; this effect is restored by B-cell transfer
In WT mice mucosal antigen application before mating resulted in significantly reduced serum titers of antigen-specific IgE and IgG 1 in the offspring (Fig 3, A and B) , again demonstrating the maternofetal transfer of tolerance and allergy protection. 17, 18 As expected, antigen-specific IgE and IgG 1 were not detectable in B cell-deficient mice (Fig 3, D and E) and also not in offspring mice around 12 weeks after B-cell transfer to the B-cell knockout mother (Fig 3, F) .
In WT mice perinatal tolerance transfer was again demonstrated by significantly reduced antigen-specific T H 2 cytokine levels in cell-culture supernatants of splenocytes and bronchial lymph node cells after restimulation with OVA (Fig 3, C and  D) . In contrast, in the same setting T H 2 cytokine levels were significantly increased in the offspring of B cell-deficient mice that had received OVA mucosally before mating (Fig 3, E) . As seen for airway inflammation, reconstitution of B cell-deficient mice by B-cell transfer reversed this increase and led to significantly reduced T H 2 cytokine levels.
In summary, mucosal antigen application before conception reduced allergic symptoms in WT offspring, whereas it aggravated allergic airway inflammation in the B cell-deficient progeny in an antigen-specific manner. B cells were crucial for perinatal tolerance transfer and protection because reconstitution of B cell-deficient mice by means of B-cell transfer resulted in abrogation of the proallergenic effect in their offspring.
Impaired Treg cell priming and intrauterine OVA transfer in B cell-deficient mice
A central mechanism in maternofetal tolerance priming is the induction of antigen-specific Treg cells. 16, 19 B cell-deficient mMT mice are known to have disturbed Treg cell expansion, 27, 30 and indeed, we observed reduced frequencies of Treg cells in 2-week-old mMT pups (Fig 4, A) . OVA-exposed WT dams, KO: OVA-exposed B cell-deficient mothers, Med: medium alone, OVA-IC, and OVA alone). KO, B cell-deficient mice. All bars display means 1 SEMs. *P < .05, **P < .01, and ***P < .001.
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To test whether this Treg cell deficiency also affected maternofetal priming of antigen-specific Treg cells, we transferred antigen-specific CD4 1 T cells from OVA-T-cell receptor transgenic OT-II mice to 1-day-old WT and B cell-deficient pups of naive and OVA-tolerized murine mothers. Two weeks later, the frequency of Foxp3 1 Treg cells within the transferred OVA-specific CD4
1 T-cell population in spleens and lymph nodes of recipient pups was analyzed. A significantly higher rate of antigen-specific Treg cells was observed in WT compared with B cell-deficient offspring (Fig 4, B) , illustrating a marked deficiency in maternofetal antigen-specific Treg cell priming in B cell-deficient mice.
To explore by which mechanism prenatal maternal antigen exposure modulated the pups' immune response and how the observed marked deficiency in maternofetal Treg cell priming might influence previous observations in our allergic airway inflammation model, we next investigated the amount, fate, and tolerogenic potential of intrauterine-transferred antigen in WT and B cell-deficient mice. Because we could not track OVA in the AF or on fetal DCs after preconception mucosal antigen administration alone, murine mothers treated with OVA before conception received an additional high-dose fluoOVA administered intravenously shortly before analyses of intrauterine transfer and fetal DC tracking.
When we compared the in utero targeting of maternally administered antigen, higher proportions of fluoOVA 1 fetal splenic and thymic DCs were observed in the fetuses of OVA-exposed WT mothers compared with those of OVA-exposed B cell-deficient mothers (Fig 4, C) . Moreover, transfer of intravenously administered OVA to the AF was far more efficient in WT mothers, and, as expected, intrauterine OVA-specific IgG was only observed in tolerized WT but not in B cell-deficient mothers (Fig 4, D Next, we were interested to study the implications of this differential AF composition in WT versus B cell-deficient mice with regard to antigen-specific tolerance and Treg cell priming in the offspring. For this purpose, we isolated T cells from OT-II donor mice that are transgenic for an OVA-specific T-cell receptor. Moreover, we isolated DCs from WT fetal mice and cocultured them with OVA-specific T cells and the AF of pregnant WT or B cell-deficient mice, which were either naive or OVA tolerized. In this coculture, AF from WT mothers induced a significant increase in antigen-specific CD4
1

CD25
hi Foxp3 
hi Foxp3 1 Treg cells was significantly reduced. In contrast, AF from B cell2deficient mothers was not as effective in priming a tolerogenic T-cell response (Fig 4, F-H) .
Transplacental antigen targeting to Fcg receptorhigh DCs is augmented by immune complexing
To further understand the interplay of antigen, immunoglobulins, and DCs during intrauterine immune priming, we next compared the phenotype and function of fetal and adult DCs. In both WT and B cell-deficient mice, fetal DCs expressed the Fcg receptor (FcgR) CD16/32 significantly stronger than their adult counterparts (Fig 5, A and B) . CD16/32 binds ICs, 31 and OVA-IC uptake was significantly stronger in fetal than adult DCs, with the strongest uptake in CD16/32 FcgR hi fetal DCs (Fig 5, C-E) . To test whether this highly efficient IC uptake by fetal DCs was also relevant in vivo, pregnant B cell-deficient mothers exposed to OVA before conception received fluoOVA or IgG/fluoOVA ICs intravenously, and the antigen uptake of fetal DCs was analyzed. Indeed, also in vivo, IgG complexing of OVA significantly increased antigen uptake in B cell-deficient fetal DCs (Fig 5, F and G) .
Next, we tested the relevance of IC-augmented antigen uptake in DCs derived from human cord blood and human peripheral blood from adults. Also in the human setting, OVA uptake was significantly boosted by means of immune complexing in DCs from both adults and cord blood donors (Fig 5, H) , and the ratio of OVA-positive DCs after OVA-IC versus OVA coincubation alone was significantly higher in cord blood samples (Fig 5, I , and see Fig E6) . These observations point to a central role of immune complexing in fetal DC antigen uptake also in human subjects.
DISCUSSION
Our data demonstrate the strong effect of B cells in perinatal tolerance priming. We show that maternal antigen exposure before conception induces antigen-specific tolerance in the WT offspring but aggravates allergic airway inflammation in the progeny of B cell-deficient mice. B cell-deficient mice show a marked impairment of maternofetal Treg cell priming during lactation and significantly reduced intrauterine antigen transfer and uptake by fetal DCs. Both WT and B cell-deficient fetal DCs express strikingly high levels of FcgR and are highly efficient in taking up IgG-complexed OVA. Moreover, we found fetal DCs to induce antigen-specific Treg cells when coincubated with OVA/IgG-containing AF of WT dams but not when coincubated with AF of OVA-exposed B cell-deficient mice.
The observed intrauterine antigen transfer in WT mice and its potency in immunologic priming support previous findings on the critical role of intrauterine OVA transfer in WT mice. Uthoff et al 26 showed that in utero-transferred maternal antibodies inhibit the offspring's T-cell antigen-specific responses. In addition, we show that this process is critically regulated by IgG and significantly impaired in the absence of B cells. Moreover, we present the novel finding that AF from tolerized WT mothers primes Treg cells, an observation thus far only described for IC containing breast milk of antigen-exposed dams. 16 Our experiments demonstrate that IgG is central in promoting intrauterine antigen transfer, antigen targeting to fetal DCs, and priming of antigen-specific Treg cells. Although our experimental setup might be nonphysiologic to the point that we used mature antigen-specific T cells to assess potential priming effects of AF, whereas T-cell maturation in mice is not completed in utero, our results still point to a decisive role of B cells and antigenspecific IgG in the early shaping of T-cell responses. This notion is further supported by recent work by Gupta et al, 32 who showed effective tolerance induction in a mouse model of hemophilia. In their model, intrauterine transfer of IgG Fc-fused Factor VIII led to effective intrauterine DC targeting of this protein with consecutive promotion of Treg cells in the pups, which were protected from antigen-specific alloimmunization in later life.
One of our most surprising findings was the antigen-specific proallergenic effect of maternal antigen application in B celldeficient mice. Our results suggest that in the absence of B cells, low doses of antigen are transferred in utero and induce a proallergenic, effector T cell-biased immune response. This observation fits to the previously described deficiency of B cell-deficient mice in low antigen dose-induced oral tolerance 33 and the strong dose dependency of mucosal tolerance development. 34 Importantly, our findings expand previous knowledge on the immune-priming effect of maternal IC containing body fluids, which had primarily focused on breast milk, to the prenatal period 16, 19, [35] [36] [37] [38] and go in line with our previous finding that maternofetally induced tolerance can be achieved in WT pups, even if the offspring are not nursed by their allergen-exposed mother but by an antigen-naive wet nurse. 17 We chose our previously described approach of preconceptional application of high antigen doses because this protocol had been shown to induce tolerance in WT offspring mice, and it ensured induction of OVA-specific IgG before and during early pregnancy. 17, 18 Our own work and that of many others support the notion that the perinatal phase (including pregnancy and lactation) represents a favorable time window to induce profound antigen-specific tolerance. [16] [17] [18] [19] 32, 39 Because our main interest was to analyze how the mother's exposure to harmless antigens before conception influences the allergy risk in the offspring, we chose to administer high doses of mucosal antigen to the mother before (Fig 5, A) and frequency (Fig 5, B) E, Uptake in specific DC subsets (6 mice/group, 2 experiments). F and G, Uptake of OVA-IC by total fetal DCs after injection of OVA alone (OVA) or OVA-IC (IC) to B cell-deficient pregnant mothers (means of 2 experiments, each including n > _ 5 fetuses per group). H and I, Antigen uptake in human adult (black and white bar) versus cord blood (dotted dark grey and dotted light bar) DCs after incubation with OVA or OVA-IC (Fig 5, H) and ratio of OVA IC/OVA antigen uptake (Fig 5, I ) from individual donors (data from n 5 7 donors per group, data from 3 experiments). All bars display means 1 SEMs. KO, Knockout. *P < .05, **P < .01, and ***P < .001.
mating, which was similar to the approach previously described by our group. 17, 18 For our main in vivo experiments, we chose the intranasal route of antigen administration because this approach had been demonstrated to be highly effective in intragenerational tolerance induction, 29, 40 as well as transmaternal tolerization. 16, 19 Although the proallergenic effect of maternal OVA administration varied from experiment to experiment, B cell-deficient offspring mice consistently showed no or inversed effects of maternal tolerization compared with WT offspring mice in the allergic airway inflammation model. Previously, we described that maternofetal tolerance priming induced before conception depended on the transfer of IgG and did not occur in neonatal Fc receptor (FcRn)-deficient mice lacking the neonatal receptor for diaplacental IgG transfer. 17, 41 However, FcRn is also important in shuffling albumin proteins through the placenta. 42 Hence, intrauterine transfer of the model allergen OVA was also hindered in FcRn-deficient mice, which completely prevented prenatal antigen-specific T-cell priming in this strain. 17, 32 By contrast, through specific knockout and reintroduction of B cells and IgG, our current in vivo and in vitro experiments allowed for comparison of specific immunologic effects of free OVA versus OVA/IgG-IC in the perinatal setting.
Our findings on intrauterine antigen/IgG transfer might also be relevant in human subjects. It has been shown that common asthma allergens, as well as allergen-specific IgG, can be delivered transplacentally to the human fetus. [43] [44] [45] [46] [47] [48] For infectious antigens, such as plasmodium proteins, it was demonstrated that human diaplacental antigen transfer is facilitated when these proteins are bound to specific IgG and transferred in IC form. 49 Interestingly, IgG transfused to human mothers, for example in pregnant women receiving intravenous immunoglobulins, is effectively transferred to the offspring through the placenta and breast milk. 50 Another striking finding in our study that supports a central role for immunoglobulin fusion in intrauterine antigen trafficking was the highly significant increase in FcgR expression on murine fetal DCs and the enhanced OVA-IC uptake in fetal over adult DCs. Also, in human adult and cord blood DCs, antigen uptake was significantly boosted by immune complexing. Together with our in vitro data and recent findings by others on Treg cell induction after intrauterine Fc-fused antigen exposure, 32 this suggests that fetal DCs are remarkably efficient in taking up ICs and priming tolerogenic T-cell responses. Of note, also other Fc receptors, especially FcRn, are upregulated in murine perinatal antigen-presenting cells, 51, 52 and we cannot exclude that these might have also contributed to the enhanced IC uptake by fetal DCs observed in our model.
One of the immediate effects of IC binding is accumulation of antigen on the cell surface, which is associated with DC maturation and enhanced antigen internalization and presentation, 31, 53 leading to modulation or suppression of immune responses in mice and human subjects. 19, [54] [55] [56] [57] More than 15 years ago, Machiels et al 57, 58 treated asthmatic patients using intradermal inoculation with IC manufactured from allergen extract and excess autologous IgG. They observed a remarkable treatment response, and a similar IC therapy success was later observed in patients with allergic rhinitis.
Although obvious differences between murine and human immune ontology exist, gestation generally appears to be a favorable time window to prime immunologic tolerance in human subjects as well. 17, 32, 59, 60 A recent article demonstrated that already in human cord blood, around 1% to 3% of the CD4
1 T cells display a memory phenotype. 61 Children born in the farming environment, which is known to protect from allergies, display higher rates of Treg cells and a tolerogenic cytokine response upon leukocyte stimulation at birth. 62, 63 However, although it is still unclear by which exact mechanisms and to what extent this early priming affects the development of allergies in later life, these findings suggest that a tolerogenic T-cell memory protecting the child from allergies can be primed prenatally in human subjects as well. 64 To further understand the relevance of our findings, future work will focus on analyzing the exact composition and modification of murine and human antigen-specific immunoglobulins and ICs that are transferred in utero and on their nature in healthy human pregnancies and mothers and neonates with allergic predisposition. In the long term, this might contribute to an improved understanding of perinatal immunity and the development of potent prevention strategies for allergy and asthma.
In conclusion, our current work supports a decisive role for B cells and immunoglobulins during in utero tolerance priming. It shows that one mechanism by which maternal antigen experience shapes the offspring's immune response is intrauterine transfer of ICs. This appears to be a protective mechanism, introducing the neonatal immune system to antigens and defining Treg cellworthy friend or effector T cell-requiring foes. Our data improve the understanding of perinatal immune priming and might support the development of effective primary prevention strategies in asthma in the future. . allergic, OVA-allergic group; control, control group; tolerized, OVA-tolerized group. *P < .05, **P < .01, and ***P < .001. (Fig E4, A) and detection of B220 1 IgD 1 cells in bone marrow by means of flow cytometry (Fig E4, B) of transplanted B cell-deficient mice more than 2 months after transplantation and mating. C, Total and OVAspecific IgM production, as assessed by using ELISpot assays of splenocytes. D and E, OVA-specific IgG (Fig E4, D) but no OVA-specific IgE (Fig E4, E) production after B-cell transfer (1-3 representative mice from > _2 experiments with n > _ 5 mice per group). KO, Knockout; n.d., not determined; Tx, transplantation. 
